Pursuant to the Regulation 32(6) of the SEBI LODR Regulations, 2015 read with Regulation 173A of SEBI ICDR Regulations, 2018, enclosed herewith is the Monitoring Agency Report for the quarter ....

KEI Industries Limited Registered and Corporate Office: D-90, Okhla Industrial Area, Phase-1, New Delhi- 110020 CIN: L74899DL1992PLC051527 Tel.: +91-11-26818840/8642/0242, Email: info@kei-ind.com Website: www.kei-ind.com Date: 03.08.2026 The Manager, The Manager, Listing Operation, Listing Division, BSE Limited, The National Stock Exchange of India Ltd., 25th Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Mumbai- 400 001. Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 517569 NSE Symbol: KEI Sub: Monitoring Agency Report for the quarter ended June 30, 2026 Dear Sir / Madam, Pursuant to the Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 173A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, enclosed herewith is the Monitoring Agency Report for the quarter ended June 30, 2026 issued by CARE Ratings Limited, Monitoring Agency for the utilisation of the proceeds raised through Qualified Institutions Placement. The Monitoring Agency Report has been duly reviewed and taken on record by the Audit Committee & the Board of Directors of the Company in their meeting held on August 03, 2026. The aforesaid information is also being made available on the website of the Company at https://www.kei-ind.com/ This is for your information and record. Thanking You Yours truly, For KEI INDUSTRIES LIMITED (KISHORE KUNAL) Sr.VP (CORPORATE FINANCE) & COMPANY SECRETARY FCS No.: 9429 CARE/NRO/GEN/2026-27/1083 The Board of Directors KEI industries Limited D-90, Okhla Industrial Area Phase-I, New Delhi-110020, India August 3, 2026 Dear Sir/Mam, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the QIP of KEI Industries Limited (“the Company”) We write in our capacity of Monitoring Agency for the Qualified institutional placement for the amount aggregating to Rs. 2,000.00 crore of the Company and refer to our duties cast under 173A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated November 25th, 2024. Request you to kindly take the same on records. Thanking you, Yours faithfully, Sahil Goyal Associate Director Sahil.Goyal@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: KEI Industries Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Nil Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an ‘expert’ as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Sahil Goyal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Gautam Budh Nagar, Uttar Pradesh -201301 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : KEI Industries Limited Name of the promoters : Mr. Anil Gupta & Mrs. Archana Gupta Industry/sector to which it belongs : Wires & Cables 2) Issue Details Issue Period : 25th November 2024 to 28th November 2024, Date of allotment: 28th November 2024 Type of issue : Qualified Institutional Placement Type of specified securities : Equity shares IPO Grading, if any : Not applicable Issue size (in `crore) : Rs. 2,000.00 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Comments Source of information / certifications Comments of the of the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of preparation of report Directors Whether all utilization is as per the disclosures in the Offer CA certificate*, Bank statements, Placement No Yes Refer Note 1 Document? document Comments Whether shareholder approval has been obtained in case No of material deviations# from expenditures disclosed in the Not applicable Not applicable Not applicable Comments Offer Document? Whether the means of finance for the disclosed objects of No No Management undertaking Nil the issue have changed? Comments Is there any major deviation observed over the earlier CA certificate*, Bank statements, Placement No deviation from earlier No monitoring agency reports? document monitoring agency reports Comments Whether all Government/statutory approvals related to the No Yes Management undertaking Nil object(s) have been obtained? Comments Whether all arrangements pertaining to technical No Not applicable Management undertaking Nil assistance/collaboration are in operation? Comments Are there any favorable/unfavorable events affecting the No No Management undertaking Refer Note 1 viability of these object(s)? Comments Is there any other relevant information that may materially No Management undertaking Nil No CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, Noida, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - Gautam Budh Nagar, Uttar Pradesh -201301 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Comments Source of information / certifications Comments of the of the Particulars Reply considered b [Showing first 8,000 characters — download PDF for full document]